Chang Jae C
Department of Medicine, University of California School of Medicine, Irvine, CA 92603 USA.
Thromb J. 2020 Oct 14;18:25. doi: 10.1186/s12959-020-00231-0. eCollection 2020.
Disseminated intravascular coagulation (DIC) can be correctly redefined as disseminated intravascular microthrombosis based on "two-path unifying theory" of in vivo hemostasis. "DIC" is a form of vascular microthrombotic disease characterized by "microthrombi" composed of platelets and unusually large von Willebrand factor multimers (ULVWF). Microthrombotic disease includes not only "DIC", but also microthrombosis occurring in thrombotic thrombocytopenic purpura (TTP), TTP-like syndrome, and focal, multifocal and localized microthrombosis. Being a hemostatic disease, microthrombotic disease occurs as a result of lone activation of ULVWF path via partial in vivo hemostasis. In endothelial injury associated with critical illnesses such as sepsis, the vascular damage is limited to the endothelial cell and activates ULVWF path. In contrast, in intravascular traumatic injury, the local damage may extend from the endothelial cell to subendothelial tissue and sometimes beyond, and activates both ULVWF and tissue factor (TF) paths. When endotheliopathy triggers exocytosis of ULVWF and recruits platelets, ULVWF path is activated and promotes microthrombogenesis to produce microthrombi composed of microthrombi strings, but when localized vascular damage causes endothelial and subendothelial tissue damage, both ULVWF and TF paths are activated and promote macrothrombogenesis to produce macrothrombus made of complete "blood clots". Currently, "DIC" concept is ascribed to activated TF path leading to fibrin clots. Instead, it should be correctly redefined as microthrombosis caused by activation of ULVWF path, leading to endotheliopathy-associated microthrombosis. The correct term for acute "DIC" is disseminated microthrombosis-associated hepatic coagulopathy, and that for chronic "DIC" is disseminated microthrombosis without hepatic coagulopathy. TTP-like syndrome is hematologic phenotype of endotheliopathy-associated microthrombosis. This correct concept of "DIC" is identified from novel theory of " hemostasis", which now can solve every mystery associated with "DIC" and other associated thrombotic disorders. Thus, sepsis-associated coagulopathy is not "DIC", but is endotheliopathy-associated vascular microthrombotic disease.
基于体内止血的“双途径统一理论”,弥散性血管内凝血(DIC)可被正确重新定义为弥散性血管内微血栓形成。“DIC”是一种血管微血栓性疾病,其特征为血小板和超大血管性血友病因子多聚体(ULVWF)组成的“微血栓”。微血栓性疾病不仅包括“DIC”,还包括血栓性血小板减少性紫癜(TTP)、TTP样综合征中发生的微血栓形成,以及局灶性、多灶性和局限性微血栓形成。作为一种止血性疾病,微血栓性疾病是由于体内部分止血过程中ULVWF途径的单独激活而发生的。在脓毒症等危重病相关的内皮损伤中,血管损伤仅限于内皮细胞并激活ULVWF途径。相反,在血管内创伤性损伤中,局部损伤可能从内皮细胞延伸至内皮下组织,有时甚至更广泛,并激活ULVWF和组织因子(TF)途径。当内皮病变引发ULVWF的胞吐作用并募集血小板时,ULVWF途径被激活并促进微血栓形成,产生由微血栓串组成的微血栓,但当局部血管损伤导致内皮和内皮下组织损伤时,ULVWF和TF途径均被激活并促进大血栓形成,产生由完整“血凝块”组成的大血栓。目前,“DIC”的概念归因于导致纤维蛋白凝块的激活TF途径。相反,它应被正确重新定义为由ULVWF途径激活引起的微血栓形成,导致内皮病变相关的微血栓形成。急性“DIC”的正确术语是弥散性微血栓形成相关的肝脏凝血病,慢性“DIC”的正确术语是无肝脏凝血病的弥散性微血栓形成。TTP样综合征是内皮病变相关微血栓形成的血液学表型。“DIC”的这一正确概念是从“止血”新理论中确定的,该理论现在可以解决与“DIC”和其他相关血栓性疾病相关的每一个谜团。因此,脓毒症相关凝血病不是“DIC”,而是内皮病变相关的血管微血栓性疾病。